Bindinglaw

US · guidance

CMS Pub. 100-02, ch. 16, § 100

Hearing Aids and Auditory Implants

activein force · 2026-08-25 – presentas-observed

Section 1862(a)(7) of the Social Security Act states that no payment may be made under

part A or part B for any expenses incurred for items or services “where such expenses are

for . . . hearing aids or examinations therefore. . . .” This policy is further reiterated at

42 CFR 411.15(d) which specifically states that “hearing aids or examination for the

purpose of prescribing, fitting, or changing hearing aids” are excluded from coverage.

Hearing aids are amplifying devices that compensate for impaired hearing. Hearing aids

include air conduction devices that provide acoustic energy to the cochlea via stimulation

of the tympanic membrane with amplified sound. They also include bone conduction

devices that provide mechanical energy to the cochlea via stimulation of the scalp with

amplified mechanical vibration or by direct contact with the tympanic membrane or

middle ear ossicles.

Certain devices that produce perception of sound by replacing the function of the middle

ear, cochlea or auditory nerve are payable by Medicare as prosthetic devices. These

devices are indicated only when hearing aids are medically inappropriate or cannot be

utilized due to congenital malformations, chronic disease, severe sensorineural hearing

loss or surgery.

The following are prosthetic devices:

• Cochlear implants and auditory brainstem implants, i.e., devices that replace the

function of cochlear structures or auditory nerve and provide electrical energy to

auditory nerve fibers and other neural tissue via implanted electrode arrays.

• Osseointegrated implants, i.e., devices implanted in the skull that replace the

function of the middle ear and provide mechanical energy to the cochlea via a

mechanical transducer.

Medicare contractors deny payment for an item or service that is associated with any

hearing aid as defined above. See §180 for policy for the medically necessary treatment

of complications of implantable hearing aids, such as medically necessary removals of

implantable hearing aids due to infection.

History

(Rev. 39; Issued: 11-10-05; Effective: 11-10-05; Implementation: 12-12-05)

Provenance

Source
cms.gov
Retrieved
2026-08-25
Edition
iom-2026-08-25
Content hash
05d9d83ba1eda3796f3beb0c9a607892f0f57566dd569ededbbc1f8c47052721
View the official source →

The link goes to the issuing authority’s own document — the one we read to produce this record. Where a source publishes whole titles rather than sections, your browser may need a moment to jump to the provision.

Unofficial copy of government-published law, reproduced from official sources with full provenance. Not an official publication; verify against official sources before relying on it in a filing. Records in the 'guidance' corpus, and only that corpus, are sub-regulatory (interpretive guidelines, survey procedures) and are not binding law. Validity bounds follow each jurisdiction's declared temporalBasis.

Coverage · API docs

Bindinglaw

Point-in-time US law with the receipt attached. Source URL, retrieval time, content hash, and validity dates on every answer.

curl api.binding.law/v1/law/coverage

© 2026 binding.law · a Jubal, Inc. productAttorneys and firms never pay. Ever.
CMS Pub. 100-02, ch. 16, § 100 — Hearing Aids and Aud… · binding.law